Welcome to Visited Lingnan Modern Clinics In Surgery, Today is

Lingnan Modern Clinics in Surgery ›› 2020, Vol. 20 ›› Issue (06): 796-800.DOI: 10.3969/j.issn.1009-976X.2020.06.022

• Review • Previous Articles     Next Articles

Research of DNA methylation in breast cancer

GUO Yu-juan, FENG Ying-ye, WANG Yong-nan, YAN Shan-shan   

  1. 1. Department of Pathology; 2. Department of Breast Disease Center, Guangdong Women and Children Hospital, Guangzhou 511400, China
  • Contact: YAN Shan-shan,yanshanshan2009@163.com

乳腺癌基因甲基化的研究进展

郭玉娟1, 冯映业1, 王永南2, 严珊珊1,*   

  1. 广东省妇幼保健院 1.病理科,2.乳腺科,广州 511400
  • 通讯作者: *严珊珊,Email:yanshanshan2009@163.com

Abstract: The molecular mechanism of breast cancer remains unclear. Studies have shown that abnormal gene expression caused by Epigenetics changes is also an important reason for the occurrence and development of breast cancer. Epigenetic changes are heritable changes in gene expression without changes in nucleotide sequence, which including DNA methylation, histone acetylation, chromatin remodeling, genomic imprinting, non-coding RNA, and so on. DNA methylation of breast is a common molecular event with unique DNA methylation characteristics. Previous studies have found that DNA methylation can be used as a molecular marker for early diagnosis, classification, monitoring of drug treatment effect and prognosis of breast cancer. This article will review the research progress of DNA methylation in breast cancer.

Key words: breast cancer, DNA methylation

摘要: 乳腺癌的发生的分子机制仍然不明确。研究显示表观遗传学改变(Epigenetics)所导致的基因表达异常也是乳腺癌发生、发展的重要原因。表观遗传学改变是基因的核苷酸序列不发生改变的情况下基因表达的可遗传的变化,包括DNA甲基化、组蛋白乙酰化、染色质重塑、基因组印记以及非编码RNA等。乳腺腺的DNA甲基化是常见的分子事件,具有独特的DNA甲基化特征,既往的研究发现DNA甲基化可以作为乳腺癌早期诊断、分型、监测药物治疗效果和预后的分子标志物。本文将对DNA甲基化在乳腺癌的研究进展进行综述。

关键词: 乳腺癌, DNA甲基化

CLC Number: